Abstract
Staphylococci are among the leading causes of nosocomial infections. Increasing insusceptibility to β-lactams and the glycopeptides complicates treatment of these infections. This review examines the current status and future perspectives for the therapy of infections caused by Staphylococcus aureus and coagulase-negative staphylococci. © 2007 Elsevier B.V. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | S23-S32 |
Journal | International Journal of Antimicrobial Agents |
Volume | 29 |
Issue number | Suppl. 3 |
DOIs | |
Publication status | Published - May 2007 |
Keywords
- antibiotics
- antimicrobial resistance
- coagulase-negative staphylococci
- staphylococcus aureus